Seres Therapeutics, Inc. SEC filings MCRB

Seres Therapeutics, Inc. has 724 filings in SEC EDGAR's recent list, going back to Jun 9, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Seres Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change
Oct 26, 2026 Oct 22, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, Agreement ended
Aug 4, 2026 Jul 31, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jul 8, 2026 Jul 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 8, 2026 Jul 8, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 5, 2026 Jun 2, 2026
8-K Current report
Officer or director change
Jun 1, 2026 May 30, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
8-K Current report
Other events
Mar 16, 2026 Mar 16, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Mar 12, 2026 Mar 12, 2026
8-K Current report
Officer or director change
Mar 2, 2026 Feb 27, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Oct 3, 2025 Sep 23, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change
Jul 22, 2025 Jul 17, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2025 May 7, 2025
8-K Current report
Bylaw or fiscal year change
Apr 22, 2025 Apr 21, 2025
8-K Current report
Officer or director change, Shareholder vote results, Other events
Apr 14, 2025 Apr 10, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 13, 2025 Mar 13, 2025
8-K Current report
Officer or director change
Feb 27, 2025 Feb 22, 2025
8-K Current report
Officer or director change
Feb 6, 2025 Feb 4, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Results of operations, Other events
Jan 10, 2025 Jan 9, 2025
8-K Current report
Results of operations, Listing notice, Regulation FD disclosure
Nov 13, 2024 Nov 7, 2024
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Oct 1, 2024 Sep 30, 2024
8-K Current report
Shareholder vote results
Sep 26, 2024 Sep 26, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 12, 2024 Sep 12, 2024
8-K Current report
Regulation FD disclosure
Aug 15, 2024 Aug 15, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Aug 6, 2024 Aug 5, 2024
8-K Current report
Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report May 7, 2024 May 1, 2024
8-K Current report
Listing notice
Apr 23, 2024 Apr 19, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Apr 8, 2024 Apr 4, 2024
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 26, 2024 Feb 24, 2024
8-K Current report
Other events
Jan 30, 2024 Jan 30, 2024
8-K Current report
Results of operations
Jan 10, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
8-K Current report
Bylaw or fiscal year change
Jan 2, 2024 Jan 2, 2024
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Officer or director change
Oct 4, 2023 Oct 2, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Jun 28, 2023 Jun 27, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 22, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2023 May 9, 2023
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure, Other events
Apr 27, 2023 Apr 26, 2023
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Officer or director change
Jan 5, 2023 Jan 4, 2023
8-K Current report
Material agreement
Dec 14, 2022 Dec 9, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Material agreement
Jun 30, 2022 Jun 29, 2022
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 22, 2022
8-K Current report
Regulation FD disclosure, Other events
Jun 7, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
8-K Current report
Regulation FD disclosure
Apr 6, 2022 Apr 6, 2022
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Regulation FD disclosure
Jul 22, 2021 Jul 22, 2021
8-K Current report
Material agreement
Jul 1, 2021 Jul 1, 2021
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 16, 2021
8-K Current report
Material agreement
May 21, 2021 May 21, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
May 20, 2021 May 20, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
8-K Current report
Results of operations
Mar 2, 2021 Mar 2, 2021
8-K Current report
Officer or director change
Feb 1, 2021 Jan 29, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Agreement ended, Bylaw or fiscal year change
Dec 7, 2020 Dec 3, 2020
8-K Current report
Regulation FD disclosure
Nov 20, 2020 Nov 20, 2020
8-K Current report
Material agreement
Aug 14, 2020 Aug 12, 2020
8-K Current report
Regulation FD disclosure, Other events
Aug 10, 2020 Aug 10, 2020
8-K Current report
Shareholder vote results
Jun 22, 2020 Jun 18, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
8-K Current report
Officer or director change
Mar 23, 2020 Mar 20, 2020
8-K Current report
Material agreement, Other events
Mar 18, 2020 Mar 18, 2020
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
8-K Current report
Officer or director change
Dec 16, 2019 Dec 12, 2019
8-K Current report
Material agreement
Nov 27, 2019 Nov 27, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Material agreement, New debt
Nov 4, 2019 Oct 29, 2019
8-K Current report
Officer or director change
Aug 6, 2019 Aug 5, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Shareholder vote results, Other events
Jun 14, 2019 Jun 13, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
8-K Current report
Officer or director change
Apr 18, 2019 Apr 18, 2019
8-K Current report
Material agreement
Mar 11, 2019 Mar 11, 2019
8-K Current report
Results of operations
Mar 6, 2019 Mar 6, 2019
8-K Current report
Officer or director change
Jan 15, 2019 Jan 13, 2019
8-K Current report
Officer or director change
Nov 21, 2018 Nov 16, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Material agreement
Nov 7, 2018 Nov 1, 2018
8-K Current report
Officer or director change
Oct 22, 2018 Oct 17, 2018
8-K Current report
Officer or director change
Sep 4, 2018 Aug 30, 2018
8-K Current report
Regulation FD disclosure
Aug 7, 2018 Aug 7, 2018
8-K Current report
Results of operations
Aug 2, 2018 Aug 2, 2018
8-K Current report
Shareholder vote results
Jun 27, 2018 Jun 26, 2018
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2018 May 9, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Mar 8, 2018 Mar 8, 2018
8-K Current report
Officer or director change
Jan 31, 2018 Jan 30, 2018
8-K Current report
Regulation FD disclosure
Jan 8, 2018 Jan 8, 2018
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
8-K Current report
Regulation FD disclosure
Oct 16, 2017 Oct 16, 2017
8-K Current report
Results of operations
Aug 3, 2017 Aug 3, 2017
8-K Current report
Officer or director change
Jul 10, 2017 Jul 7, 2017
8-K Current report
Shareholder vote results
Jun 21, 2017 Jun 20, 2017
8-K Current report
Regulation FD disclosure
Jun 12, 2017 Jun 12, 2017
8-K Current report
Officer or director change
Jun 9, 2017 Jun 7, 2017
8-K Current report
Results of operations
May 4, 2017 May 4, 2017
8-K Current report
Results of operations, Regulation FD disclosure
Mar 16, 2017 Mar 16, 2017
8-K Current report
Regulation FD disclosure
Jan 31, 2017 Jan 31, 2017
8-K Current report
Shareholder vote results
Jun 17, 2016 Jun 15, 2016
8-K Current report
Results of operations
Feb 25, 2016 Feb 25, 2016
8-K Current report
Officer or director change
Feb 4, 2016 Feb 3, 2016
8-K Current report
Material agreement
Jan 11, 2016 Jan 9, 2016
8-K Current report
Results of operations, Officer or director change
Nov 10, 2015 Nov 9, 2015
8-K Current report
Results of operations
Aug 6, 2015 Aug 6, 2015
8-K Current report
Bylaw or fiscal year change
Jul 1, 2015 Jul 1, 2015

Showing 122 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MCRB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1609809
Former names
Seres Therapeutics, Inc. (until Nov 4, 2026); Seres Health, Inc. (until May 14, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.